NCT01303341 2026-03-18
Riluzole and Sorafenib Tosylate in Treating Patients With Advanced Solid Tumors or Melanoma
National Cancer Institute (NCI)
Phase 1 Active not recruiting
Clinical Trials
3 trialsNCT00866840 2024-01-19
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Cannot Be Removed by Surgery
Rutgers, The State University of New Jersey
Phase 2 Completed
NCT00667901 2009-12-11
Riluzole in Treating Patients With Stage III or Stage IV Melanoma That Can Be Removed by Surgery
Rutgers, The State University of New Jersey
Phase 1 Terminated